title: [The effect of 6% HES 200/0.6-0.66 on plasma volume and blood coagulation].
abstract: The main goal of the recent study was to evaluate changes in plasma volume due to the application of 6% HES 200/0.6-0.66. 12 patients according to the ASA physical status classification (I, II) undergoing minor surgical interventions received 500 ml of this artificial plasma substitute within 30 min. In a control group (n = 12), 500 ml of lactated Ringer's solution was given within the same period. A further question of the present investigation was the possible influence of 6% HES on coagulation during the following period (1st-3rd postoperative days). 6% HES 200/0.6-0.66 led to an additional augmentation of plasma volume measured via the mechanical oscillator technique of 200 ml (40% of the volume given) immediately at the end of infusion. A second increase in plasma volume of 100 ml (20% of the volume infused) could be observed 1 h later. With exception of the activity of factor VIII, the coagulation parameters had not been altered by infusion of 6% HES. The activity of factor VIII decreased to about 50% of the control level but showed a tendency to normalization within the following observation period. 6% HES 200/0.6-0.66 has a marked volume-expanding effect and exerts no influence on coagulation except a temporary decrease of factor VIII activity.
authors.affiliation: Universitätsklinik für Anästhesiologie, Karl-Franzens-Universität Graz, Osterreich.
authors.forename: W
authors.initials: W
authors.lastname: Kröll
authors.forename: P
authors.initials: P
authors.lastname: Gerner
authors.forename: T
authors.initials: T
authors.lastname: Colombo
authors.forename: H
authors.initials: H
authors.lastname: Ramschak
authors.forename: H
authors.initials: H
authors.lastname: Hinghofer-Szalkay
authors.forename: W F
authors.initials: WF
authors.lastname: List
mesh_terms: D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D001809:Blood Viscosity / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D006400:Hematocrit; D006438:Hemodilution; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage*; D007552:Isotonic Solutions / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care; D000077325:Ringer's Lactate
chemical_list: D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D000077325:Ringer's Lactate